entity
alzheimer's
probable ad
non-childbearing potential
mild cognitive impairment
dementia
post-menopausal females
pre-menopausal females with a documented (medical report verification) hysterectomy and/or bilateral oophorectomy
the patient must have successfully completed the full 78-week duration of the double-blind cl-758007 study
reasonably good nutritional status
female subjects must be post-menopausal
pre-menopausal or who have been post-menopausal for <1 year must undertake pregnancy testing (urine test) at visit 1, which must be negative
females must be non-child-bearing potential.
male patients with female partners of child-bearing potential should use effective contraception for the duration of the study.
completed the 12 month visit of 49653/461 (12 months of treatment) without tolerability issues
female subjects must be post-menopausal
not pregnant
female (post-menopausal or surgically sterile
ad
no history or evidence of any other cns disorder that could be interpreted as a cause of dementia
no diagnosis of vascular dementia
no history of significant psychiatric illness such as schizophrenia or bipolar affective disorder
no evidence of the following: current vitamin b12 deficiency, positive syphilis serology, positive hiv test, or abnormalities in thyroid function
no cognitive rehabilitation
no history of drug or alcohol abuse
cardiac history
no history of uncontrolled seizure disorder
no history of malignancy
women cannot be pregnant or breastfeeding
must have been ongoing in trx-014-001 at time of study termination
no history of significant psychiatric illness such as schizophrenia or bipolar affective disorder.
no evidence of the following: current vitamin b12 deficiency, positive syphilis serology, positive hiv test, or abnormalities in thyroid function~no cognitive rehabilitation within 6 months of the study
giving informed consent to lumbar puncture
adequate english literacy to complete neuropsychological testing
generally stable level of health
amnestic mci
no evidence of cognitive impairment by medical history
early stage of ad
maximum of 2 cups of black tea/die
no green tea
not more than > 500 ml/die of grapefruit juice
probable alzheimer´s disease
treated stable hypertension
menopause women
her/his spouse consent with contraception during the study period and 90 days after end of study
amnestic or non-amnestic mild cognitive impairment
hypovitaminosis d (i.e., serum 25-hydroxyvitamin d [25ohd]concentration < 30 ng/ml)
no hypercalcemia (defined as serum calcium concentration ≥ 2,65 mmol/l)
females must be > 2 years post-menopausal or surgically sterile
randomized into study m10-985 and completed dosing through week 24
male, the subject is surgically sterile (vasectomy, is sexually inactive, or is using a barrier method of birth control (condom) with spermicidal foam/gel/film/cream/suppository
postmenopausal for at least 2 years or is surgically sterile
inclusion criteria:~previous participation in study abe4869g or abe4955g and completion of the week 73 visit
male participants with partners with reproductive potential, agreement to use a reliable means of contraception (e.g., condoms)
female participants, a negative pregnancy test
amci
history of academic achievement and/or employment sufficient to exclude mental retardation
membership in psen1 e280a mutation carrier kindred
does not meet criteria for dementia due to ad
does not meet criteria for mild cognitive impairment (mci) due to ad
surgically sterile (absence of ovaries and/or uterus) or postmenopausal
use a condom as a method of contraception
mild to moderate probable ad
primary degenerative dementia
completed visit 7 (completion visit) in the lead-in double-blind, placebo controlled clinical studies 14861a/nct01955161 or 14862a/nct02006641
completed visit 6 (week 28) of the olex
do not have a history of major depression
mci due to ad,
dementia due to possible or probable ad
fertile, sexually active subjects (men and women) must use an effective method of contraception
willing to practice adequate methods of contraception if of childbearing potential
mci due to ad
ad dementia
postmenopausal or surgically sterile females only
amnestic and non-amnestic mci
mild cognitive impairment (mci) due to probable ad or of mild ad
female patients must be either surgically sterile or at least 2 years postmenopausal
childbearing potential must be using highly effective contraception
early signs of dementia of alzheimer type
women must be neither pregnant nor nursing, and are either surgically sterile, postmenopausal or premenopausal using an acceptable method of contraception.
no known allergy or oversensitivity against valaciclovir or aciclovir
amyloid beta positivity
mild cognitive impairment (amnestic or amnestic plus other) with biomarkers that suggest intermediate or high likelihood that the syndrome is due to ad
female subject with child-bearing potential agrees to take reliable contraceptive method
female, postmenopausal
non-smoker
no active history of suicide attempt
more than 1 lifetime suicide attempt
mild ad
mci or dementia due to ad
completion of participation in the anavex2-73-ad-004 double-blind study
suicidal behavior
mild-to-moderate ad dementia
dementia, due probably to ad
mild to moderate ad
probable alzheimer dementia
prodromal ad
use contraceptive methods
mci or ad
probable mild to moderate ad dementia
probable ad dementia
mild ad or moderate ad
gradual and progressive change in memory function
negative serum pregnancy test
mild cognitive impairment (mci)
subjects who can walk with or without assist device
completed lead-in protocol tb006ad2102 (participants from both study drug and placebo groups) or are eligible for the lead-in study but were not enrolled (de novo)
contraceptive use by men should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies
ambulatory
mild cognitive impairment or mild dementia
completed rethink-alz (pti-125-07) or refocus-alz (pti-125-06)
negative urine pregnancy test
male participants must be sterile or sexually inactive or agree not to father a child
no evidence of current suicidal ideation or previous suicide attempt in the past 2 months as evaluated in the columbia suicide severity rating scale nor suicidal behavior
good general health
completion of the planned treatment period in the al002-2 study
good work history sufficient to exclude mental retardation
preserved activities of daily living
alternative causes of cognitive decline are ruled out
no contraindications to the mri
alzheimer's disease
without focal deficits (excluding changes attributable to peripheral nervous system disease, trauma or congenital birth deficits)
consistent with the diagnosis of ad
consistent with a diagnosis of ad
consistent with alzheimer's disease
compatible with the diagnosis of probable alzheimer's disease
excluding another structural brain disease
mild to moderate (not severe) white matter hyperintensities
medical stability
rules out non-ad conditions contributing to cognitive dysfunction
consistent with the diagnosis of dementia due to ad without any other clinically significant comorbid pathologies
evidence of amyloid pathology
consistent with a diagnosis of probable alzheimer's disease (ad)
consistent with the diagnosis of alzheimer's disease
allowed but not required
consistent with the clinical diagnosis of alzheimer's disease
reduced perfusion or reduced metabolism bilaterally temporally, hippocampal atrophy
pathological markers for alzheimer's disease
hetero or homozygote
biomarker supportive of ad as the underlying pathology
normal
within normal limits
diagnosis of probable ad
pattern typical for ad
show the highest possibility of ad
evidence of ad pathological process
confirmed with a diagnosis of ad
presence of amyloid pathology
no other diseases to cause dementia other than ad
result consistent with the presence of brain amyloid pathology
suggestive of ad
congruent with the diagnosis
findings consistent with the diagnosis of ad and without any other clinically significant comorbid pathologies
confirmed amyloid beta pathology
consistent with the presence of amyloid pathology
lower memory performance
